NewAmsterdam Pharma Co. N.V. (NAMS)
Market Closed
16 Oct, 08:00 PM
$
19. 83
-0.79
-3.8312%
$
2.41B Market Cap
- P/E Ratio
- Div Yield
1.94M Volume
-1.92 Eps
$ 20.62
Previous Close 
Want to track NAMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NewAmsterdam Pharma Co. N.V. (NAMS) Statistics
Valuation metrics
Market Cap 2.41B
Enterprise value 2.1B
Trailing P/E (ttm) -9.9
Forward P/E -
PEG ratio 0.29
Price/Sales (ttm) 354.19
Price/Book (mrq) 4.22
Enterprise Value/Revenue 294.64
Enterprise Value/EBITDA -8.23
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.77M
Average volume (90 days) 1.58M
Price summary
52-Week low 19.58
52-Week high 42.21
Beta -
50-Day moving average 22.59
200-Day moving average 32.18
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -36.44%
Operating margin -34.32%
Operational effectiveness
Return on assets -0.37%
Return on equity -0.38%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.1
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.14
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 9.03%
Book value per share (mrq) 5.12
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
